Logotype for Omnicell Inc

Omnicell (OMCL) Q4 2023 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Omnicell Inc

Q4 2023 earnings summary

7 Nov, 2026

Executive summary

  • FY2023 revenue was $1.147B, down 11% YoY; Q4 revenue was $259M, down 13% YoY.

  • Advanced Services revenue grew 14% to $213M, reaching 19% of FY revenue; FY2024 target is 21%.

  • FY2024 guidance: revenue of $1.045B–$1.120B and non-GAAP EBITDA of $90M–$120M.

  • Management plans a holistic business review to optimize investment and accelerate profitability.

Financial highlights

  • Q4 non-GAAP gross margin was 43.6%, down 170 bps YoY; non-GAAP operating expenses were $103M, down 17%.

  • Q4 non-GAAP EBITDA was $24M versus $26M YoY; diluted non-GAAP EPS was $0.33, unchanged YoY.

  • FY2023 non-GAAP EBITDA was $137.9M versus $192.9M; non-GAAP diluted EPS was $1.91 versus $3.00.

  • FY2023 GAAP net loss was $20.4M, versus net income of $5.6M in FY2022; non-GAAP net income was $87M.

  • Lower Point of Care revenue reflected healthcare systems’ capital budget and labor constraints.

Outlook and guidance

  • FY2024 revenue guidance is $1.045B–$1.120B; product revenue $605M–$650M and service revenue $440M–$470M.

  • FY2024 technical services and Advanced Services revenue are each guided to $220M–$235M; Advanced Services target is 21% of total revenue.

  • FY2024 bookings guidance is $750M–$875M; non-GAAP EBITDA is $90M–$120M and non-GAAP EPS is $0.90–$1.40.

  • Q1 2024 revenue guidance is $232M–$242M; non-GAAP EBITDA is $(2)M–$4M and non-GAAP EPS is $(0.10)–$0.00.

  • Free cash flow is expected to slow as investment continues in the transition to Advanced Services.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more

Latest events from Omnicell